Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

INDELVAR: structure-informed prediction of in-frame indel pathogenicity with calibrated PP3/BP4 thresholds

Created on 19 Aug 2026

Authors

Ji, E., Oh, S. H., Kim, I.-S.

Abstract

In-frame insertions and deletions are difficult to interpret because their effects depend on both the sequence change and its protein context. We developed INDELVAR, a random forest model for in-frame insertions and deletions of 1-10 amino acids that integrates 37 features describing AlphaFold-derived wild-type structural context, evolutionary conservation, local sequence change, gene constraint, and curated protein annotations. Pathogenic variants more often affected protein regions with high AlphaFold confidence, low solvent exposure, dense local packing, and strong evolutionary conservation. INDELVAR showed high discrimination in cross-validation with the area under the receiver operating characteristic curve (AUROC) of 0.980, and in an independent test set, an AUROC of 0.977. INDELVAR achieved higher AUROCs than the evaluated methods for both deletions and insertions, although the differences from a recent protein language model-based method were not significant. With separate calibration for deletions and insertions, INDELVAR reached strong evidence on both the pathogenic and benign sides for each type, a range not previously reported for an in-frame indel predictor. In independent testing, all represented evidence intervals met their corresponding likelihood ratio requirements. A precomputed resource provides scores for 372,090 observed in-frame indels mapped to Genome Reference Consortium Human Build 38.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 19 Aug 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 19
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement